Atractylenolide III
Atractylenolide III Basic information
- Product Name:
- Atractylenolide III
- Synonyms:
-
- Atractylenolide III (ICodonolactone
- ICodonolactone
- ATRACTYLENOLIDE III
- 8-HYDROXYASTEROLIDE
- ATRACTYLENOLIDE
- Atractylenolide beta
- (4aS,8aR,9aS)-9a-Hydroxy-3,8a-dimethyl-5-methylidene-4,4a,6,7,8,9-hexahydrobenzo[f][1]benzoxol-2-one
- (4aS)-4a,5,6,7,8,8a,9,9a-Octahydro-9aβ-hydroxy-3,8aβ-dimethyl-5-methylenenaphtho[2,3-b]furan-2(4H)-one
- CAS:
- 73030-71-4
- MF:
- C15H20O3
- MW:
- 248.32
- Product Categories:
-
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Miscellaneous Natural Products
- Mol File:
- 73030-71-4.mol
Atractylenolide III Chemical Properties
- Melting point:
- 166-169 °C(Solv: chloroform (67-66-3))
- Boiling point:
- 424.6±45.0 °C(Predicted)
- Density
- 1.18±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- methanol: soluble1mg/mL, clear, colorless
- pka
- 10.73±0.60(Predicted)
- form
- powder or crystals
- color
- white to off-white
- biological source
- Atractylodes macrocephala Koidz.
- InChI
- InChI=1S/C15H20O3/c1-9-5-4-6-14(3)8-15(17)12(7-11(9)14)10(2)13(16)18-15/h11,17H,1,4-8H2,2-3H3/t11-,14+,15-/m0/s1
- InChIKey
- FBMORZZOJSDNRQ-GLQYFDAESA-N
- SMILES
- O1C(=O)C(C)=C2C[C@]3([H])[C@@](C)(C[C@]12O)CCCC3=C
Safety Information
- WGK Germany
- 3
- Hazardous Substances Data
- 73030-71-4(Hazardous Substances Data)
Atractylenolide III Usage And Synthesis
Chemical Properties
White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from Atractylodes macrocephala Koidz.
Uses
Atractylenolide III enhances energy metabolism by increasing the SIRT-1 and PGC1α expression.
Definition
ChEBI: Atractylenolide III is a naphthofuran. It has a role as a metabolite.
Biological Activity
Atractylenolide III possesses anti-inflammatory and anticancer properties.
in vivo
Atractylenolide III (5 and 10 mg/kg, p.o.) shows gastroprotective effects and reduces 70% ethanol-induced gastric ulcer in rats[2].
Atractylenolide III (30 mg/kg, oral gavage for 14 days or 28 days) reduces depressive- and anxiogenic-like behaviors in rat depression models in Lipopolysaccharide (LPS) (HY-D1056) and chronic unpredictable mild stress (CUMS) induced rat depression model[5].
| Animal Model: | 70% ethanol-induced gastric ulcers in rats[2] |
| Dosage: | 5 and 10 mg/kg |
| Administration: | p.o. |
| Result: | Inhibited gastric ulcer formation and the necrotic erosion of gastric mucosa. Downregulated the MMP-2/9 expression by activating the TIMP-2 and TIMP-1 expressions. |
Atractylenolide IIISupplier
- Tel
- 021-38218169 13681877033
- 2702713455@qq.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
- Tel
- 400-1166-196 18981987031
- cdhxsj@163.com
- Tel
- 0086-21-58956006
Atractylenolide III(73030-71-4)Related Product Information
- Dimethyl sebacate
- Dimethyl fumarate
- Dimethyl ether
- D-(+)-Glucono-1,5-lactone
- N,N-Dimethylformamide
- Spironolactone
- Dimethyl carbonate
- Dimethyl phthalate
- ETHANE
- Dimethyl sulfoxide
- Atractylenolide-1
- 2-ATRACTYLENOLIDE
- ISOAMYL TIGLATE
- 5-HYDROXY-4-METHYL-2(5H)FURANONE
- ETHYL TRANS-2-DECENOATE
- HEXYL TIGLATE
- BUTYL TIGLATE
- ATRACTYLENOLIDE Ⅲ